Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme

Journal of Child Neurology

Volumn 28, Issue 8, 2013, Pages 1002-1008

  Maroon, Joseph ^a   Bost, Jeffrey ^a   Amos, Austin ^a   Zuccoli, Giulio ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

glioblastoma multiforme; glycolysis; ketogenic diet; Warburg Effect

Indexed keywords

4 PHENYLBUTYRIC ACID; ANTINEOPLASTIC AGENT; CORTICOSTEROID; DEOXYGLUCOSE; GLUCOSE; GLUTAMIC ACID;

BRAIN TUMOR; CALORIC RESTRICTION; CANCER CELL; CANCER RADIOTHERAPY; CANCER SURGERY; CELL ENERGY; CENTRAL NERVOUS SYSTEM TUMOR; CHEMOPROPHYLAXIS; CONFERENCE PAPER; ENERGY METABOLISM; GENE ACTIVATION; GLIOBLASTOMA; HUMAN; KETOGENIC DIET; NONHUMAN; PHYTONUTRIENT; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; TUMOR GROWTH; UNITED STATES;

EID: 84880158378     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813488670     Document Type: Conference Paper

References (44)

1. Zuccoli G, Marcello N, Pisanello A, et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted calorie ketogenic diet: case report. Nutr Metab. 2010 ; 7: 33
2. Ohgaki H, Kleihues P. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci. 2009 ; 100: 2235-2241
3. Tso CL, Shintaku P, Chen J, et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006 ; 4: 607-619
4. Chen R, Nishimura MC, Bumbaca SM, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010 ; 17: 362-375
5. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009 ; 10: 459-466
6. Mason WP, Maestro RD, Eisenstat D, et al. Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol. 2007 ; 14: 110-117
7. Kitange GJ, Carlson BL, Schroeder MA, et al. Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro-Oncology. 2009 ; 11: 281-291
8. Hegi ME, Diserens A, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 ; 352: 997-1003
9. Warburg O, Wind F, Negelein E.. The metabolism of tumors in the body. J Gen Physiol. 1927 ; 8: 519-530
10. Warburg O. On the origin of cancer cells. Science. 1956 ; 123: 309-314
11. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg Effect in carcinogenesis. J Biol Chem. 2002 ; 277: 23111-23115
12. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg Effect: the metabolic requirements of cell proliferation. Science. 2009 ; 324: 1029-1033
13. Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochimica et Biophysica Acta. 2011 ; 1807: 577-594
14. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics. 2000 ; 105: e46
15. Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics. 2007 ; 119: 535-543
16. Hartman AL, Vining AP. Clinical aspects of the ketogenic diet. Epilepsia. 2007 ; 48: 31-42
17. Sirven J, Whedon B, Caplan D, et al. The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia. 1999 ; 40: 1721-1726
18. Seyfried TN, Mukherjee P. Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab. 2005 ; 2: 30
19. Seyfried TN, Mukherjee P, Kalamian M, Zuccoli G. The restricted calorie ketogenic diet: an alternative treatment strategy for glioblastoma multiforme. Treatment Strategies - Oncol. 2011 ;: 1-12
20. Potts R Humanity's Descent: The Consequences of Ecological Instability. New York, NY: William Morrow ; 1996:
21. Seyfried TN Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. Hoboken, NJ: John Wiley ; 2012:
22. Seyfried TN, Shelton LM, Mukherjee P. Does existing standard of care increase glioblastoma energy metabolism?. Lancet Oncol. 2010 ; 11: 811-813
23. McCay CM, Crowell MF, Maynard MA. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr. 1935 ; 10: 63-69
24. Guarente L. Mitochondria - a nexus for aging, calorie restriction, and sirtuins?. Cell. 2008 ; 132: 171-176
25. Kennedy BK, Austriaco NR, Zhang J, Guarente L. Mutations in silencing gene SIR4 can delay aging in S. cerevisiae. Cell. 1995 ; 80: 485-496
26. Sinclair D. Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev. 2005 ; 126: 987-1002
27. Lewis KN, Mele J, Hayes JD, Beffenstein R. Nrf2, a guardian of healthspan and gatekeeper of species longevity. Integr Comp Biol. 2010 ; 50: 829-843
28. Park LK, Friso S, Chio SW. Nutritional influences on epigenetics and age-related diseases. Proc Nutr Soc. 2012 ; 71: 75-83
29. Marsh J, Mukherjee P, Seyfried TN. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted calorie ketogenic diet. Nutr Metab. 2008 ; 5: 33
30. Zhu Z, Jiang W, McGinley JN. Thompson HJ. 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Res. 2005 ; 65: 7023-7030
31. Minor RK, Smith DL, Sossong AM, et al. Chronic ingestion of 2-deoxy-d-glucose induces cardiac vacuolization and increases mortality in rats. Toxicol Appl Pharmacol. 2010 ; 243: 332-339
32. Batshaw ML, MacArthur RB, Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr. 2002 ; 140: 490
33. Gilbert J, Baker SD, Bowling MK, et al. A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies. Clin Cancer Res. 2001 ; 7: 2292-2300
34. Otto C, Kaemmerer U, Illert B, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008 ; 8: 122
35. Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002 ; 86: 1615-1621
36. Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr. 1995 ; 14: 202-208
37. Schmidt M, Pfetzer N, Schwab M, Strauss I, Kämmerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab. 2011 ; 8: 54
38. Keijer J, Bekkenkamp-Grovenstein M, Venema D, Dommels Y. Bioactive food components, cancer cell growth limitation and reversal of glycotic metabolism. Biochimica et Biophysica Acta. 2011 ; 1807: 697-706
39. Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by reseveratrol: in vitro and in vivo studies and the underlying mechanism (review). Intl J Oncol. 2003 ; 23: 17-28
40. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004 ; 24: 2783-2840
41. Nagle DG, Zhou Y. Natural product-based inhibitors of Hypoxia-inducible Factor-1 (HIF-1). Curr Drug Targets. 2006 ; 7: 355-359
42. Hardman EW. Omega-3 fatty acids to augment cancer therapy. J Nutr. 2002 ; 132: 3508-3512
43. Novotny L, Rauko P, Cojocel C. Alpha-lipoic acid: the potential use in cancer therapy. Neoplasma. 2008 ; 55: 81-86
44. Wenzel U, Nickel A, Daniel H.. α-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-generation. Apoptosis. 2005 ; 10: 359-368